Etiqa Insurance Singapore Brings Everyday Readiness to Public Spaces through "When Life Spins, Stay Ready" Campaign

Interactive out-of-home activation across Mind, Body and Money aims to generate more than 10,000 readiness responses from Singaporeans

SINGAPORE - Media OutReach Newswire - 11 June 2026 - Etiqa Insurance Singapore is bringing the conversation on everyday readiness into public spaces with 'When Life Spins, Stay Ready', an interactive out-of-home activation that invites Singaporeans to reflect on their sense of readiness across three everyday dimensions: Mind, Body and Money, while challenging the notion that being prepared is not solely reserved for moments of crisis, but built in small, everyday choices we make.

Etiqa Insurance Singapore Brings Everyday Readiness to Public Spaces through "When Life Spins, Stay Ready" Campaign

This light-hearted and reflective activation encourages Singaporeans to consider everyday preparedness in a new light. It aims to kickstart conversations around readiness in life while reinforcing Etiqa's commitment to helping customers navigate life with greater confidence and support.

Rolling out across selected high-traffic locations from June 2026, 'When Life Spins, Stay Ready' is designed to make readiness simple, engaging and relatable. Participants can register onsite, answer a short set of quiz questions, and stand a chance to win exciting prizes through a prize-wheel spin.

Across 42 activation days, participants will answer six questions across three readiness pillars: Mind, Body and Money, with at least four correct answers required to stand a chance at winning a spin-and-win prize. Up to 4,000 prizes will be available for redemption, subject to qualifying criteria, campaign terms and verification.

The quiz questions are mapped to practical everyday behaviours. The Mind pillar explores how Singaporeans manage stress and prioritise rest, the oft-overlooked foundations of mental resilience. Body examines the small physical habits that sustain us, from how much we move to whether we stay adequately hydrated. Money spotlights the budgeting instincts and saving behaviours that determine how well-prepared we are when life takes an unexpected turn.

By exploring these themes, Etiqa aims to help Singaporeans see readiness not as something reserved for major life events or moments of crisis, but as something shaped by the choices they make every day.

"Readiness is only about preparing for the unexpected but is also about the everyday habits and decisions that help people feel more confident about what lies ahead," said Claudia Soh, Acting CEO of Etiqa Insurance Singapore. "Through When Life Spins, Stay Ready, we hope to inspire Singaporeans to adopt readiness as a lifelong mindset — one that empowers them to face life with greater assurance and resilience."

The initiative builds on Etiqa's broader brand platform, Live Ready With You, which reflects our commitment to helping customers navigate life with greater confidence and support. The activation also sets the stage for the upcoming Etiqa Life Preparedness Survey, released in the second half of 2026. The research, conducted by Kantar, will offer a deeper look into how Singaporeans approach preparedness across financial security, physical wellbeing and mental resilience.

For the latest activation details, follow Etiqa Singapore on Instagram and TikTok at @etiqasg, or visit www.etiqa.com.sg/stayready.

Activation Locations and Dates

The activation will run for a total of 6 weeks, starting with City Hall MRT on 11 June 2026. For details on other locations, pls visit https://www.etiqa.com.sg/stayready/

Hashtag: #Etiqa #WhenLifeSpinsStayReady

The issuer is solely responsible for the content of this announcement.

About Etiqa Insurance Pte. Ltd (Etiqa Insurance Singapore)

Protecting customers since 1961, Etiqa Insurance Singapore is a licensed life and general insurance company regulated by the Monetary Authority of Singapore (MAS) and governed by the Insurance Act 1966. The local insurer is the Singapore operating entity of Etiqa Insurance Group – a leading insurance and Takaful business in ASEAN offering life and general insurance and family and general Takaful products through its agents, branches, offices and bancassurance network in the region. Etiqa Insurance Singapore is rated 'A' by credit rating agency Fitch for the group's 'Favorable' business profile and 'Very Strong' capitalisation.

Etiqa Insurance Singapore is owned by Maybank Ageas Holdings Berhad, a joint venture company that combines local market knowledge with international insurance expertise. The company is 69% owned by Maybank, the fourth largest banking group in Southeast Asia, and 31% by Ageas, an international insurance group with footprints across 13 countries and a heritage that spans over 190 years.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTR-CM in Australia, Singapore, South Korea, and Taiwan. The partnership combines BridgeBio’s biotech innovation and DKSH Healthcare’s integrated end-to-end commercialization platform to bring a new treatment option to patients.

SINGAPORE - EQS Newswire - 11 June 2026 - DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provider of Market Expansion Services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, has entered a distribution partnership with BridgeBio, a biotechnology company focused on genetic diseases. Under the terms of the agreement, DKSH will be responsible for the distribution and commercialization of the transthyretin stabilizer for ATTR-CM across Australia, Singapore, South Korea, and Taiwan.

Where approved, the product is indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization¹. ATTR-CM is a progressive, debilitating disease that diminishes quality of life, causes recurrent hospitalizations, and leads to premature death. This new treatment is not currently approved in the countries covered by this agreement and any commercialization will be subject to applicable regulatory approvals and local regulations.

DKSH will provide end-to-end solutions prioritizing healthcare access to patients, leveraging its expertise in regulatory affairs, medical affairs, market access, and launch excellence, as well as its robust distribution infrastructure and integrated commercial capabilities. DKSH is well positioned to support the introduction of this biotech innovation across the Territory following regulatory approvals.^{2 3 4}

"Our strategic partnership with BridgeBio represents an important milestone as DKSH Healthcare enters a new chapter with a renewed vision for growth. United by a shared commitment to improve outcomes for underserved patients, we are proud to combine BridgeBio's scientific innovation with DKSH Healthcare's industry‑leading, end‑to‑end commercialization platform. Leveraging our deep market expertise, strong capabilities, and trusted execution across complex healthcare systems, we are well positioned to launch this biotech innovation and expand access to important new treatment options reliably, responsibly, and at scale, advancing on our mission to deliver Healthcare for All," said Patrik Grande, Global Head of Business Unit Healthcare, DKSH.

¹ FDA, Full Prescribing Information. Available at:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216540s000lbl.pdf Last accessed March 2026.
² Lane T, et al. Circulation. 2019;140(1):16-26.
³ Rintell D, et al. Orphanet J Rare Dis. 2021;16(1):70.
⁴ Nativi-Nicolau J, et al. ESC Heart Fail. 2021;8(5):3875-3884Hashtag: #DKSH

The issuer is solely responsible for the content of this announcement.

About DKSH

For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, e-commerce, distribution and logistics as well as after-sales services, following its purpose of enriching people's lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 26,840 specialists, generating net sales of CHF 11.1 billion in 2025. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,580 specialists, the Business Unit generated net sales of CHF 5.8 billion in 2025. www.dksh.com/hec

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **